An hour before the market closed on Thursday, as news reports of Trump's choice began trickling out, Covid-19 vaccine maker Moderna dipped as much as 6 per cent, and Pfizer fell almost 2 per cent.Judge concerned by luxury hotel rapist's denialKennedy has been one of the country's most prominent anti-vaccine conspiracy theorists for years and has frequently spread falsehoods about the safety and efficacy of vaccines.
Last week, Kennedy said he would "immediately" begin studying vaccine safety and efficacy but promised to not "take vaccines away from anybody."Other vaccine-related companies also felt the fallout. German company BioNTech closed 7 per cent lower, and British GSK fell 2 per cent. US vaccine companies have already been struggling, thanks to lessened demand since the peak of the pandemic.READ MORE:Robert F. Kennedy Jr., speaks before Republican presidential nominee former President Donald Trump at a campaign rally at Madison Square Garden, Sunday, Oct. 27, 2024, in New York.
While Pfizer revenue and profits soared during the peak of the pandemic – generating nearly $US57 billion in combined sales in 2022, thanks largely to its Comirnaty Covid-19 vaccine and Paxlovid antiviral pill – the boom subsided by early 2023, and the company slashed its expectations for Covid-related sales.After Trump made the announcement official, the stocks fell further.
"The Safety and Health of all Americans is the most important role of any Administration, and HHS will play a big role in helping ensure that everybody will be protected from harmful chemicals, pollutants, pesticides, pharmaceutical products, and food additives that have contributed to the overwhelming Health Crisis in this Country," Trump said in a post